GENESTE
ActiveSummary
The annual accounts of GENESTE for financial year 2025 show a net loss of 58% of the equity at the start of that year. The 2025 annual accounts show equity of €2,414 and a net result of -€3,314. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 20% of 16,824 sector peers (NACE 68, financial year 2025). The company has been active since 1967 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-03
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-09
Financial
Weakest financial yearnet -€3,314
Net result drops to -€3,314, the lowest in the series.
28-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
19-02
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
13-04
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
04-03
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
30-09
Financial
Highest result from 2019 to 2025net €27,311 ▲149%
Operating result €42,505, net result €27,311, both a record.
12-02
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
30-09
Financial
Back to profitnet €10,968
Net result €10,968 after one loss-making year.
17-02
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
19-03
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
21-03
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
23-03
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 48 annual accounts filed, the latest 10 are here; all 48 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.